Arsenic Trioxide and Resveratrol Show Synergistic Anti-Leukemia Activity and Neutralized Cardiotoxicity

Cardiotoxicity is an aggravating side effect of many clinical antineoplastic agents such as arsenic trioxide (As(2)O(3)), which is the first-line treatment for acute promyelocytic leukemia (APL). Clinically, drug combination strategies are widely applied for complex disease management. Here, an opti...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Yuhua, Chen, Meng, Meng, Jia, Yu, Lei, Tu, Yingfeng, Wan, Lin, Fang, Kun, Zhu, Wenliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140836/
https://www.ncbi.nlm.nih.gov/pubmed/25144547
http://dx.doi.org/10.1371/journal.pone.0105890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140836/
https://www.ncbi.nlm.nih.gov/pubmed/25144547
http://dx.doi.org/10.1371/journal.pone.0105890

Ejemplares similares